{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T14:05:41Z","timestamp":1785852341667,"version":"3.56.0"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,4]]},"DOI":"10.1097\/01.mcg.0000155126.82171.32","type":"journal-article","created":{"date-parts":[[2005,3,9]],"date-time":"2005-03-09T04:02:18Z","timestamp":1110340938000},"page":"303-306","source":"Crossref","is-referenced-by-count":50,"title":["Association of Anti-tumor Necrosis Factor Therapy With the Development of Multiple Sclerosis"],"prefix":"10.1097","volume":"39","author":[{"given":"Pedram J","family":"Enayati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos A","family":"Papadakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-9-20210305","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1056\/NEJM199710093371502","article-title":"A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohns disease: Crohns Disease cA2 Study Group.","volume":"337","author":"Targan","year":"1997","journal-title":"N Engl J Med"},{"key":"R2-9-20210305","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1056\/NEJM200305223482121","article-title":"Immunogenicity of infliximab in Crohns disease.","volume":"348","author":"Hanauer","year":"2003","journal-title":"N Engl J Med"},{"key":"R3-9-20210305","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1056\/NEJM199905063401804","article-title":"Infliximab for the treatment of fistulas in patients with Crohns disease.","volume":"340","author":"Present","year":"1999","journal-title":"N Engl J Med"},{"key":"R4-9-20210305","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1046\/j.1365-2036.2003.01739.x","article-title":"Infliximab in the treatment of medically refractory indeterminate colitis.","volume":"18","author":"Papadakis","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"R5-9-20210305","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1016\/S0016-5085(03)00382-2","article-title":"Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohns disease.","volume":"124","author":"Van den Brande","year":"2003","journal-title":"Gastroenterology"},{"key":"R6-9-20210305","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1053\/j.gastro.2003.10.047","article-title":"The safety profile of infliximab in patients with Crohns disease: the Mayo clinic experience in 500 patients.","volume":"126","author":"Colombel","year":"2004","journal-title":"Gastroenterology"},{"key":"R7-9-20210305","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJMoa011110","article-title":"Tuberculosis associated with infliximab, a tumor necrosis factor-neutralizing agent.","volume":"345","author":"Keane","year":"2001","journal-title":"N Engl J Med"},{"key":"R8-9-20210305","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0016-5085(03)00701-7","article-title":"Autoimmunity associated with anti-tumor necrosis factor alpha treatment in Crohns disease: a prospective cohort study.","volume":"125","author":"Vermeire","year":"2003","journal-title":"Gastroenterology"},{"key":"R9-9-20210305","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1572-0241.2003.07161.x","article-title":"Safety and steroid-sparing experience using infliximab for Crohns disease at a pediatric inflammatory bowel disease center.","volume":"98","author":"Stephens","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"R10-9-20210305","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/00054725-200401000-00004","article-title":"Demyelination during anti-tumor necrosis factor alpha therapy with infliximab for Crohns disease.","volume":"10","author":"Thomas","year":"2004","journal-title":"Inflamm Bowel Dis"},{"key":"R11-9-20210305","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S1098-3597(02)90005-0","article-title":"Inflammatory bowel disease.","volume":"4","author":"Knigge","year":"2002","journal-title":"Clin Cornerstone"},{"key":"R12-9-20210305","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/0167-5699(89)90236-3","article-title":"MS: a CNS and systemic autoimmune disease.","volume":"10","author":"Hafler","year":"1989","journal-title":"Immunol Today"},{"key":"R13-9-20210305","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1212\/WNL.30.7_Part_2.61","article-title":"Epidemiologic contributions to multiple sclerosis: an overview.","volume":"30","author":"Kurtzke","year":"1980","journal-title":"Neurology"},{"key":"R14-9-20210305","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0016-5085(91)90594-B","article-title":"Geographic variation of inflammatory bowel disease within the United states.","volume":"100","author":"Sonnenberg","year":"1991","journal-title":"Gastroenterology"},{"key":"R15-9-20210305","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0140-6736(82)90629-8","article-title":"Association of ulcerative colitis with multiple sclerosis.","volume":"2","author":"Rang","year":"1982","journal-title":"Lancet"},{"key":"R16-9-20210305","doi-asserted-by":"crossref","first-page":"802","DOI":"10.4065\/75.8.802","article-title":"Concurrence of inflammatory bowel disease and multiple sclerosis.","volume":"75","author":"Kimura","year":"2000","journal-title":"Mayo Clin Proc"},{"key":"R17-9-20210305","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1053\/gast.2000.18160","article-title":"Tumor necrosis factor: biology and therapeutic inhibitors.","volume":"119","author":"Papadakis","year":"2000","journal-title":"Gastroenterology"},{"issue":"suppl 1","key":"R18-9-20210305","first-page":"132","article-title":"The function of tumor necrosis factor and receptors in models of multi-organ inflammation, rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease.","volume":"58","author":"Kollias","year":"1999","journal-title":"Ann Rheum Dis"},{"key":"R19-9-20210305","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.1002\/1529-0131(200112)44:12<2862::AID-ART474>3.0.CO;2-W","article-title":"Demyelination occurring during anti-tumor necrosis factor alpha therapy for inflammatory arthritides.","volume":"44","author":"Mohan","year":"2001","journal-title":"Arthritis Rheum"},{"key":"R20-9-20210305","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1212\/WNL.53.3.457","article-title":"TNF neutralization in MS: results of a randomized, placebo-controlled multicenter study.","volume":"53","year":"1999","journal-title":"Neurology"},{"key":"R21-9-20210305","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1212\/WNL.47.6.1531","article-title":"Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2.","volume":"47","author":"Van Oosten","year":"1996","journal-title":"Neurology"},{"key":"R22-9-20210305","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1084\/jem.193.4.427","article-title":"Uncoupling the proinflammatory from the immunosuppressive properties of Tumor Necrosis Factor (TNF) at the p55 TNF receptor level: implications for pathogenesis and therapy of autoimmune demyelination.","volume":"193","author":"Kassiotis","year":"2001","journal-title":"J Exp Med"}],"container-title":["Journal of Clinical Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/01.mcg.0000155126.82171.32","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T13:41:24Z","timestamp":1785850884000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00004836-200504000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005]]}},"URL":"https:\/\/doi.org\/10.1097\/01.mcg.0000155126.82171.32","relation":{},"ISSN":["0192-0790"],"issn-type":[{"value":"0192-0790","type":"print"}],"subject":[],"published":{"date-parts":[[2005,4]]}}}